Skip to main content
Erschienen in: American Journal of Clinical Dermatology 5/2008

01.10.2008 | Current Opinion

Can We Define Acne as a Chronic Disease?

If So,How and When?

verfasst von: Dr Harald P.M. Gollnick, Andrew Y. Finlay, Neil Shear, on behalf of the Global Alliance to Improve Outcomes in Acne

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 5/2008

Einloggen, um Zugang zu erhalten

Abstract

There is widespread misunderstanding of acne amongst both the medical and lay community, who often perceive the condition to be a simple, self-limited affliction of adolescents. Because many think that the disease “will go away on its own,” they do not feel an urgency to aggressively treat acne. However, very often the reality is that acne treatment can be quite difficult. Furthermore, acne can be a devastating disease for the patient, since it manifests on visible body parts and in children near puberty, who are vulnerable both socially and psychologically. Most typically, acne is not an acute disease but rather a condition that continuously changes in its distribution and severity. Usually, acne treatment is necessary for many months and sometimes years. Despite treatment, acne may cause scarring and associated negative psychological effects. It is important for both patients and physicians to be aware that very effective treatments are available. It is also important to realize that new studies have proven the benefit of maintenance therapy with topical retinoids; these agents can minimize the potential for relapse, which is part of the natural history of acne. This article reviews the evidence suggesting that acne is a chronic disease in at least a subset of individuals. The members of the Global Alliance to Improve Outcomes in Acne believe that acne should be recognized and investigated as a chronic disease. This will change expectations of clinical trial design and treatment and will highlight gaps in the knowledge of acne epidemiology. The result should be an improvement in patient outcomes.
Literatur
2.
Zurück zum Zitat O’Halloran J, Miller GC, Britt H.Defining chronic conditions for primary care with ICPC-2. Fam Pract 2004; 21: 381–6PubMedCrossRef O’Halloran J, Miller GC, Britt H.Defining chronic conditions for primary care with ICPC-2. Fam Pract 2004; 21: 381–6PubMedCrossRef
3.
Zurück zum Zitat Bornman J. The World Health Organisation’s terminology and classification:application to severe disability. Disabil Rehab 2004; 26: 182–8CrossRef Bornman J. The World Health Organisation’s terminology and classification:application to severe disability. Disabil Rehab 2004; 26: 182–8CrossRef
4.
Zurück zum Zitat Cunliffe WJ. Acne. London: Martin Dunitz Ltd, 1989: 2–4 Cunliffe WJ. Acne. London: Martin Dunitz Ltd, 1989: 2–4
5.
Zurück zum Zitat Stern RS. Dermatologists and office-based care of dermatologic disease in the 21st century. J Invest Derm 2004; 9: 126–30CrossRef Stern RS. Dermatologists and office-based care of dermatologic disease in the 21st century. J Invest Derm 2004; 9: 126–30CrossRef
6.
Zurück zum Zitat Neimeir V, Kupfer J, Demmelbauer-Ebner M,eaet al. Coping with acne vulgaris: evaluation of the chronic skin disorder questionnaire in patients with acne. Dermatology 1998; 196: 108–15CrossRef Neimeir V, Kupfer J, Demmelbauer-Ebner M,eaet al. Coping with acne vulgaris: evaluation of the chronic skin disorder questionnaire in patients with acne. Dermatology 1998; 196: 108–15CrossRef
7.
Zurück zum Zitat Gollnick H, Cunliffe W, Berson D,et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49 (1 Suppl.): S1–37PubMedCrossRef Gollnick H, Cunliffe W, Berson D,et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49 (1 Suppl.): S1–37PubMedCrossRef
8.
Zurück zum Zitat Thiboutot DM, Shalita AR, Yamauchi PS, et al. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study. Arch Dermatol 2006; 142: 597–602PubMedCrossRef Thiboutot DM, Shalita AR, Yamauchi PS, et al. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study. Arch Dermatol 2006; 142: 597–602PubMedCrossRef
9.
Zurück zum Zitat Leyden J, Thiboutot DM, Shalita AR, et al. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. Arch Dermatol 2006; 142: 605–12PubMedCrossRef Leyden J, Thiboutot DM, Shalita AR, et al. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. Arch Dermatol 2006; 142: 605–12PubMedCrossRef
10.
Zurück zum Zitat Zhang ZJ, Li LF, Tu YT, et al. A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%. J Dermatolog Treat 2004; 15: 372–8PubMedCrossRef Zhang ZJ, Li LF, Tu YT, et al. A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%. J Dermatolog Treat 2004; 15: 372–8PubMedCrossRef
11.
Zurück zum Zitat Alirezai M, George SA, Coutts I,et al. Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline. Eur J Dermatol 2007; 17: 45–51PubMed Alirezai M, George SA, Coutts I,et al. Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline. Eur J Dermatol 2007; 17: 45–51PubMed
12.
Zurück zum Zitat Zane LT. Acne maintenance therapy: expanding the role of topical retinoids? Arch Dermatol 2006; 142: 638–40PubMedCrossRef Zane LT. Acne maintenance therapy: expanding the role of topical retinoids? Arch Dermatol 2006; 142: 638–40PubMedCrossRef
13.
Zurück zum Zitat Thiboutot DM, Lookingbill DP. Acne: acute or chronic disease? J Am Acad Dermatol 1995; 32: 2–5CrossRef Thiboutot DM, Lookingbill DP. Acne: acute or chronic disease? J Am Acad Dermatol 1995; 32: 2–5CrossRef
15.
Zurück zum Zitat Chew EW, Bingham A, Burrow D. Incidence of acne vulgaris in patients with infantile acne. Clin Exp Dermatol 1990; 15: 376–7PubMedCrossRef Chew EW, Bingham A, Burrow D. Incidence of acne vulgaris in patients with infantile acne. Clin Exp Dermatol 1990; 15: 376–7PubMedCrossRef
17.
Zurück zum Zitat Taylor SC, Cook-Bolden F, Rahman Z, et al. Acne vulgaris in skin of color. J Am Acad Dermatol 2002; 46: S98–106PubMedCrossRef Taylor SC, Cook-Bolden F, Rahman Z, et al. Acne vulgaris in skin of color. J Am Acad Dermatol 2002; 46: S98–106PubMedCrossRef
18.
Zurück zum Zitat Cunliffe WJ, Gould DJ. Prevalence of facial acne vulgaris in late adolescence and adults. BMJ 1979; 166: 1109–10CrossRef Cunliffe WJ, Gould DJ. Prevalence of facial acne vulgaris in late adolescence and adults. BMJ 1979; 166: 1109–10CrossRef
19.
Zurück zum Zitat Goulden V, McGeown CH, Cunliffe WJ. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol 1999; 141: 297–300PubMedCrossRef Goulden V, McGeown CH, Cunliffe WJ. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol 1999; 141: 297–300PubMedCrossRef
20.
Zurück zum Zitat Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol 2001; 15: 541–5PubMedCrossRef Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol 2001; 15: 541–5PubMedCrossRef
21.
Zurück zum Zitat Tan JKL. The Canadian Acne Epidemiological Survey: baseline demographics and interim analysis. J Am Acad Dermatol 2004; 50 Suppl. 2: P15CrossRef Tan JKL. The Canadian Acne Epidemiological Survey: baseline demographics and interim analysis. J Am Acad Dermatol 2004; 50 Suppl. 2: P15CrossRef
23.
Zurück zum Zitat Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999; 140: 273–82PubMedCrossRef Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999; 140: 273–82PubMedCrossRef
25.
Zurück zum Zitat Krowschuk DP, Stancin T, Keskinen R, et al. The psychoscial effects of acne on adolescents. Pediatr Dermatol 1991; 8 (4): 332–8CrossRef Krowschuk DP, Stancin T, Keskinen R, et al. The psychoscial effects of acne on adolescents. Pediatr Dermatol 1991; 8 (4): 332–8CrossRef
26.
Zurück zum Zitat Kilkenny M, Merlin K, Plunkett A, et al. The prevalence of common skin conditions in Australian school students: 3. Acne vulgaris. Br J Dermatol 1998; 139: 840–5PubMedCrossRef Kilkenny M, Merlin K, Plunkett A, et al. The prevalence of common skin conditions in Australian school students: 3. Acne vulgaris. Br J Dermatol 1998; 139: 840–5PubMedCrossRef
27.
Zurück zum Zitat Kilkenny M, Stathakis V, Hibbert ME,et al. Acne in Victorian adolescents: associations with age, gender, puberty and psychiatric symptoms. J Paediatr Child Health 1997; 33: 430–3PubMedCrossRef Kilkenny M, Stathakis V, Hibbert ME,et al. Acne in Victorian adolescents: associations with age, gender, puberty and psychiatric symptoms. J Paediatr Child Health 1997; 33: 430–3PubMedCrossRef
28.
Zurück zum Zitat Baldwin HE. The interaction between acne vulgaris and the psyche. Cutis 2002; 70: 133–9PubMed Baldwin HE. The interaction between acne vulgaris and the psyche. Cutis 2002; 70: 133–9PubMed
29.
Zurück zum Zitat Kligman AM. Postadolescent acne in women. Cutis 1992; 48: 218–22 Kligman AM. Postadolescent acne in women. Cutis 1992; 48: 218–22
30.
Zurück zum Zitat Smith RN, Mann NJ, Braue A,et al. The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J Am Acad Dermatol 2007; 57: 247–56PubMedCrossRef Smith RN, Mann NJ, Braue A,et al. The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J Am Acad Dermatol 2007; 57: 247–56PubMedCrossRef
31.
Zurück zum Zitat Kaymak Y, Adisen E, Ilter N, et al. Dietary glycemic index and glucose, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein 3, and leptin levels in patients with acne. J Am Acad Dermatol 2007; 57: 819–23PubMedCrossRef Kaymak Y, Adisen E, Ilter N, et al. Dietary glycemic index and glucose, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein 3, and leptin levels in patients with acne. J Am Acad Dermatol 2007; 57: 819–23PubMedCrossRef
32.
Zurück zum Zitat Treloar V, Logan AC, Danby FW,et al. Comment on acne and glycemic index. J Am Acad Dermatol 2008; 58: 175–7PubMedCrossRef Treloar V, Logan AC, Danby FW,et al. Comment on acne and glycemic index. J Am Acad Dermatol 2008; 58: 175–7PubMedCrossRef
33.
Zurück zum Zitat Schafer T, Nienhaus A, Vieluf D,et al. Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol 2001; 145: 100–4PubMedCrossRef Schafer T, Nienhaus A, Vieluf D,et al. Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol 2001; 145: 100–4PubMedCrossRef
34.
Zurück zum Zitat Till AE, Gouden V, Cunliffe WJ, et al. The cutaneous microflora of adolescent, persistent and late-onset acne patients does not differ. Br J Dermatol 2000; 142: 885–92PubMedCrossRef Till AE, Gouden V, Cunliffe WJ, et al. The cutaneous microflora of adolescent, persistent and late-onset acne patients does not differ. Br J Dermatol 2000; 142: 885–92PubMedCrossRef
35.
Zurück zum Zitat Plewig G, Kligman AM. Acne and rosacea. 3rdz ed. New York: Springer, 2000CrossRef Plewig G, Kligman AM. Acne and rosacea. 3rdz ed. New York: Springer, 2000CrossRef
36.
Zurück zum Zitat Cunliffe WJ, Gollnick HPM. Acne: diagnosis and management. London: Taylor & Francis,2001 Cunliffe WJ, Gollnick HPM. Acne: diagnosis and management. London: Taylor & Francis,2001
37.
Zurück zum Zitat Giannetti A, Girolomoni G. Atopic dermatitis. In: Fritsch P, Burgdorf W, editors. EDF-white book: skin diseases in Europe. 2nd ed. Berlin: ABW-Wissenschaftsverlag, 2005: 69–71 Giannetti A, Girolomoni G. Atopic dermatitis. In: Fritsch P, Burgdorf W, editors. EDF-white book: skin diseases in Europe. 2nd ed. Berlin: ABW-Wissenschaftsverlag, 2005: 69–71
38.
Zurück zum Zitat Burgdorf W. Acne vulgaris. In: Fritsch P, Burgdorf W, editors. EDF-white book: skin diseases in Europe. 2nd ed. Berlin: ABW-Wissenschaftsverlag, 2005: 74–6 Burgdorf W. Acne vulgaris. In: Fritsch P, Burgdorf W, editors. EDF-white book: skin diseases in Europe. 2nd ed. Berlin: ABW-Wissenschaftsverlag, 2005: 74–6
39.
Zurück zum Zitat Mallon E, Newton JN, Klassen A, et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999; 140: 672–6PubMedCrossRef Mallon E, Newton JN, Klassen A, et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999; 140: 672–6PubMedCrossRef
40.
Zurück zum Zitat Aktan S, Ozmen E, Sanli B. Anxiety, depression, and nature of acne vulgaris in adolescents. Int J Dermatol 2000; 39: 354–7PubMedCrossRef Aktan S, Ozmen E, Sanli B. Anxiety, depression, and nature of acne vulgaris in adolescents. Int J Dermatol 2000; 39: 354–7PubMedCrossRef
41.
Zurück zum Zitat Lasek RJ, Chren M-M. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 1998; 134: 454–8PubMedCrossRef Lasek RJ, Chren M-M. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol 1998; 134: 454–8PubMedCrossRef
42.
Zurück zum Zitat Thielitz A, Helmdach M, R¨opke E-M, et al. Lipid analysis of follicular casts from cyanoacrylate strips as a new method for studying therapeutic effects of antiacne agents.Br J Dermatol 2001; 145: 19–27PubMedCrossRef Thielitz A, Helmdach M, R¨opke E-M, et al. Lipid analysis of follicular casts from cyanoacrylate strips as a new method for studying therapeutic effects of antiacne agents.Br J Dermatol 2001; 145: 19–27PubMedCrossRef
43.
Zurück zum Zitat Thielitz A, Sidou F, Gollnick H. Control of microcomedone formation throughout a maintenance treatment with adapalene gel 0.1%. J Eur Acad Dermatol Venereol 2007; 21: 741–53CrossRef Thielitz A, Sidou F, Gollnick H. Control of microcomedone formation throughout a maintenance treatment with adapalene gel 0.1%. J Eur Acad Dermatol Venereol 2007; 21: 741–53CrossRef
44.
Zurück zum Zitat Cunliffe WJ, Holland DB, Clark SM,et al. Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol 2000; 142: 1084–91PubMedCrossRef Cunliffe WJ, Holland DB, Clark SM,et al. Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol 2000; 142: 1084–91PubMedCrossRef
Metadaten
Titel
Can We Define Acne as a Chronic Disease?
If So,How and When?
verfasst von
Dr Harald P.M. Gollnick
Andrew Y. Finlay
Neil Shear
on behalf of the Global Alliance to Improve Outcomes in Acne
Publikationsdatum
01.10.2008
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 5/2008
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200809050-00001

Weitere Artikel der Ausgabe 5/2008

American Journal of Clinical Dermatology 5/2008 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

16.04.2024 DGIM 2024 Nachrichten

Den Reflex, eine oberflächliche chronische Hautwunde ohne Entzündungszeichen in jedem Fall abzustreichen, sollte man nach einer neuen „Klug-entscheiden“-Empfehlung unterdrücken.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.